Pharma - Page 2 of 117

Pharmalot

Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries

By Ed Silverman

Pharmalot

Pharmalittle: NIH may own patents for the Moderna Covid-19 vaccine; ICER boosts recommended price for remdesivir

By Ed Silverman

Pharmalot

Hospitals see shortages of a cheap steroid that one study says helps Covid-19 patients

By Ed Silverman

Pharmalot

A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial

By Ed Silverman

Pharmalot

Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients

By Ed Silverman

Pharmalot

Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs

By Ed Silverman

Pharmalot

FDA urged to heighten safety warnings on common type 2 diabetes drugs

By Ed Silverman

Pharmalot

Pharmalittle: Sanofi steps up Covid-19 vaccine efforts; has a successor to FDA’s Janet Woodcock been found?

By Ed Silverman

Politics

Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs

By Ed Silverman

Pharmalot

Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose

By Ed Silverman

Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case

By Ed Silverman

Pharmalot

Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach

By Ed Silverman

Pharmalot

Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests

By Ed Silverman

Pharmalot

Pharmalittle: Trump pushes for Covid-19 vaccine by year’s end; Americans fear pharma will keep raising drug prices

By Ed Silverman

Pharmalot

A majority of Americans fear pharma will use Covid-19 as an excuse to raise prices

By Ed Silverman

Pharmalot

Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?

By Ed Silverman

Pharmalot

California attorney general says FTC failed to follow ‘best practices’ in approving AbbVie-Allergan deal

By Ed Silverman

Pharmalot

Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials

By Ed Silverman

Pharmalot

As quality concerns rise, FDA report shows Indian drug plants inspected more often — and had more problems

By Ed Silverman

Pharma

Royalty Pharma, a drug company that doesn’t develop drugs, shatters IPO record

By Damian Garde

Pharmalot

Pharmalittle: Cheap steroid reduced deaths in severe Covid-19 patients; what the FDA decision on hydroxychloroquine means

By Ed Silverman

Pharmalot

A YouTube ‘hit job’ about a Catalyst Pharma rival is posted amid its battle with the FDA

By Ed Silverman

Pharmalot

Pharmalittle: Lilly begins studying RA drug for Covid-19; AstraZeneca to provide Europe 400 million vaccine doses

By Ed Silverman

Pharmalot

A would-be chain of cancer centers wants to treat patients with Right to Try drugs, raising ethical questions

By Ed Silverman

Pharma giants to unveil major $1 billion venture to push novel antibiotics

Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs

Up and down the ladder: The latest comings and goings

Pharmalittle: Sanofi to cut hundreds of jobs; former BARDA chief claims Azar is sabotaging his new job

Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries

Pharmalittle: NIH may own patents for the Moderna Covid-19 vaccine; ICER boosts recommended price for remdesivir

Hospitals see shortages of a cheap steroid that one study says helps Covid-19 patients

A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial

Federal prosecutors allege Regeneron used a charity to pay kickbacks to Medicare patients

Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs

FDA urged to heighten safety warnings on common type 2 diabetes drugs

Pharmalittle: Sanofi steps up Covid-19 vaccine efforts; has a successor to FDA’s Janet Woodcock been found?

Lawmakers push Covid-19 bills to prevent price gouging, track federal funds used to discover drugs

Pharmalittle: Will a Covid-19 vaccine protect the elderly? Generic remdesivir to cost up to $79 a dose

Up and down the ladder: The latest comings and goings

Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case

Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach

Clinical trial costs to develop a new drug may actually be rather modest — or so one study suggests

Pharmalittle: Trump pushes for Covid-19 vaccine by year’s end; Americans fear pharma will keep raising drug prices

A majority of Americans fear pharma will use Covid-19 as an excuse to raise prices

Some Covid-19 trial sponsors never posted other study results in an EU database. Will they hide data again?

California attorney general says FTC failed to follow ‘best practices’ in approving AbbVie-Allergan deal

Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials

As quality concerns rise, FDA report shows Indian drug plants inspected more often — and had more problems

Royalty Pharma, a drug company that doesn’t develop drugs, shatters IPO record

Pharmalittle: Cheap steroid reduced deaths in severe Covid-19 patients; what the FDA decision on hydroxychloroquine means

A YouTube ‘hit job’ about a Catalyst Pharma rival is posted amid its battle with the FDA

Pharmalittle: Lilly begins studying RA drug for Covid-19; AstraZeneca to provide Europe 400 million vaccine doses

A would-be chain of cancer centers wants to treat patients with Right to Try drugs, raising ethical questions